EMEA-002986-PIP01-21 - paediatric investigation plan

Zorecimeran

Key facts

• Active Substance:
  Zorecimeran
• Therapeutic area:
  Vaccines
• Decision number:
  P/0212/2021
• PIP number:
  EMEA-002986-PIP01-21
• Pharmaceutical form(s):
  Concentrate and solvent for dispersion for injection
• Condition(s) / indication(s):
  Prevention of Coronavirus disease 2019 (COVID-19)
• Route(s) of administration:
  Intramuscular use
• Decision type:
  P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
• Decision date:
  17/05/2021

Decision

P/0212/2021: EMA decision of 17 May 2021 on the agreement of a paediatric investigation plan and on the granting of a deferral for zorecimeran (EMEA-002986-PIP01-21)

Reference Number: EMA/245833/2021